Robert Musella
OP
White_Shadow
:
Ah, the keyboard warrior graces us with their wisdom. Don’t worry—your contribution will be remembered… just like every other irrelevant comment on the internet.
I’ve been swing trading ‘em for a while; went long, months ago… singular product (DefenCath) of great importance, transitioned from R&D to production/sales. Simple. Until it wasn’t… Joe Todisco’s leadership, as CEO, troubles me. CORMEDIX INC. ANNOUNCES PRELIMINARY FOURTH QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE - CorMedix | Prevention of cardiac, renal and infectious diseases $72-78mm spending in 2025, “…largely driven by R&D,” they said? “[Co...
White_Shadow : lol. wgaf
Robert Musella OP White_Shadow : Ah, the keyboard warrior graces us with their wisdom. Don’t worry—your contribution will be remembered… just like every other irrelevant comment on the internet.
White_Shadow Robert Musella OP : i hear ya Robert Musella